Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1989 3
1990 5
1992 1
1993 1
1994 3
1995 5
1996 5
1997 4
1998 9
1999 2
2000 3
2001 2
2002 2
2003 3
2004 2
2006 2
2007 2
2008 2
2009 1
2010 1
2011 1
2012 3
2014 1
2015 1
2016 2
2020 1
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

70 results
Results by year
Filters applied: . Clear all
Page 1
Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial.
Kelly K, Altorki NK, Eberhardt WE, O'Brien ME, Spigel DR, Crinò L, Tsai CM, Kim JH, Cho EK, Hoffman PC, Orlov SV, Serwatowski P, Wang J, Foley MA, Horan JD, Shepherd FA. Kelly K, et al. Among authors: hoffman pc. J Clin Oncol. 2015 Dec 1;33(34):4007-14. doi: 10.1200/JCO.2015.61.8918. Epub 2015 Aug 31. J Clin Oncol. 2015. PMID: 26324372 Clinical Trial.
Immune hemolytic anemia--selected topics.
Hoffman PC. Hoffman PC. Hematology Am Soc Hematol Educ Program. 2009:80-6. doi: 10.1182/asheducation-2009.1.80. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008185 Review.
Immune hemolytic anemia--selected topics.
Hoffman PC. Hoffman PC. Hematology Am Soc Hematol Educ Program. 2006:13-8. doi: 10.1182/asheducation-2006.1.13. Hematology Am Soc Hematol Educ Program. 2006. PMID: 17124033 Review.
Lung cancer.
Hoffman PC, Mauer AM, Vokes EE. Hoffman PC, et al. Lancet. 2000 Feb 5;355(9202):479-85. doi: 10.1016/S0140-6736(00)82038-3. Lancet. 2000. PMID: 10841143 Review.
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
O'Donnell PH, Trubetskoy V, Nurhussein-Patterson A, Hall JP, Nath A, Huo D, Fleming GF, Ingle JN, Abramson VG, Morrow PK, Storniolo AM, Forero A, Van Poznak C, Liu MC, Chang JC, Merkel DE, Peppercorn JM, Rugo HS, Dees EC, Hahn OM, Hoffman PC, Rosner GL, Huang RS, Ratain MJ, Cox N, Olopade OI, Wolff AC, Dolan ME, Nanda R; Translational Breast Cancer Research Consortium (TBCRC). O'Donnell PH, et al. Among authors: hoffman pc. Breast Cancer Res Treat. 2020 Jun;181(3):623-633. doi: 10.1007/s10549-020-05603-8. Epub 2020 May 6. Breast Cancer Res Treat. 2020. PMID: 32378051
Concomitant chemoradiotherapy for non-small cell lung cancer.
Vokes EE, Haraf DJ, Hoffman PC, Bitran JD, Ferguson MK, Golomb HM. Vokes EE, et al. Among authors: hoffman pc. Lung Cancer. 1994 Mar;10 Suppl 1:S253-61. doi: 10.1016/0169-5002(94)91689-6. Lung Cancer. 1994. PMID: 8087518 Review.
The theoretical rationale, and clinical experience are reviewed in brief. Clinical trials conducted at the University of Chicago are summarized....
The theoretical rationale, and clinical experience are reviewed in brief. Clinical trials conducted at the University of Chicago …
Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation.
Vigneswaran J, Tan YH, Murgu SD, Won BM, Patton KA, Villaflor VM, Hoffman PC, Hensing T, Hogarth DK, Malik R, MacMahon H, Mueller J, Simon CA, Vigneswaran WT, Wigfield CH, Ferguson MK, Husain AN, Vokes EE, Salgia R. Vigneswaran J, et al. Among authors: hoffman pc. Oncotarget. 2016 Apr 5;7(14):18876-86. doi: 10.18632/oncotarget.7739. Oncotarget. 2016. PMID: 26934441 Free PMC article.
This study reviews extensive genetic analysis in advanced non-small cell lung cancer (NSCLC) patients in order to: describe how targetable mutation genes interrelate with the genes identified as variants of unknown significance; assess the percentage of patients with a potentiall …
This study reviews extensive genetic analysis in advanced non-small cell lung cancer (NSCLC) patients in order to: describe how targetable m …
Phase II trial of temsirolimus in patients with metastatic breast cancer.
Fleming GF, Ma CX, Huo D, Sattar H, Tretiakova M, Lin L, Hahn OM, Olopade FO, Nanda R, Hoffman PC, Naughton MJ, Pluard T, Conzen SD, Ellis MJ. Fleming GF, et al. Among authors: hoffman pc. Breast Cancer Res Treat. 2012 Nov;136(2):355-63. doi: 10.1007/s10549-011-1910-7. Epub 2012 Jan 13. Breast Cancer Res Treat. 2012. PMID: 22245973 Free PMC article. Clinical Trial.
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer.
Gutiontov SI, Turchan WT, Spurr LF, Rouhani SJ, Chervin CS, Steinhardt G, Lager AM, Wanjari P, Malik R, Connell PP, Chmura SJ, Juloori A, Hoffman PC, Ferguson MK, Donington JS, Patel JD, Vokes EE, Weichselbaum RR, Bestvina CM, Segal JP, Pitroda SP. Gutiontov SI, et al. Among authors: hoffman pc. Sci Rep. 2021 Oct 8;11(1):20059. doi: 10.1038/s41598-021-99524-1. Sci Rep. 2021. PMID: 34625620 Free PMC article.
70 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page